Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,011 JPY | +0.10% | -2.94% | +14.91% |
2023 | Kakuyasu Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2021 | COSMOS Pharmaceutical : Topix closes at near one-month high as investors await earnings | RE |
Sales 2024 | 129B 822M | Sales 2025 * | 142B 900M | Capitalization | 19.05B 121M |
---|---|---|---|---|---|
Net income 2024 | 1.6B 10.13M | Net income 2025 * | 2.01B 12.8M | EV / Sales 2024 | 0.15 x |
Net Debt 2024 * | 6.08B 38.64M | Net Debt 2025 * | 4.38B 27.81M | EV / Sales 2025 * | 0.17 x |
P/E ratio 2024 |
12
x | P/E ratio 2025 * |
9.41
x | Employees | 1,592 |
Yield 2024 |
2.46% | Yield 2025 * |
2.61% | Free-Float | 21.93% |
1 day | +0.10% | ||
1 week | -2.94% | ||
1 month | -7.33% | ||
3 months | +16.51% | ||
6 months | +5.51% | ||
Current year | +14.91% |
Managers | Title | Age | Since |
---|---|---|---|
Akihiko Tajima
CEO | Chief Executive Officer | 61 | 09-11-30 |
Hiroyuki Maegaki
DFI | Director of Finance/CFO | - | 02-09-30 |
Junichi Sato
CHM | Chairman | 65 | 81-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Takayuki Oshima
BRD | Director/Board Member | 69 | 21-06-24 |
Junichi Sato
CHM | Chairman | 65 | 81-02-28 |
Akihiko Tajima
CEO | Chief Executive Officer | 61 | 09-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2,011 | +0.10% | 2,900 |
24-05-30 | 2,009 | +0.15% | 8,600 |
24-05-29 | 2,006 | -1.08% | 7,700 |
24-05-28 | 2,028 | -1.55% | 5,200 |
24-05-27 | 2,060 | -0.58% | 6,300 |
Delayed Quote Japan Exchange, May 31, 2024 at 01:58 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.91% | 121M | |
-4.80% | 5.9B | |
-7.93% | 948M | |
+6.76% | 391M | |
+3.79% | 347M | |
+1.15% | 212M | |
-24.53% | 165M | |
+20.34% | 111M | |
-15.13% | 63.52M | |
+9.09% | 56.49M |
- Stock Market
- Equities
- 7686 Stock